Video

Outcomes of Fecal Microbiota Transplantation for C. difficile Infection

Author(s):

Monika Fischer, MD, discusses the outcomes of a study assessing fecal microbiota transplantation for c. difficile infection at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.

Monika Fischer, MD, discusses the outcomes of fecal microbiota transplantation for c. difficile at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.

She talks about the safety and efficacy of her research findings and how that will further encourage her work.

“The overall efficacy was 88%. The conclusion from our study is that yes, fecal transplant is a highly successful procedure: however, in order to achieve a 90% or higher cure rate, we most likely need to administer 2 or more fecal transplants," said Fischer.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.